Kamada (KMDA) Operating Income Growth (1y) (2013 - 2026)
Kamada (KMDA) Operating Income Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 32.63 Bn | 30.69 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn | -14.89% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | 21.25% |
| 10 | Kamada | 400.07 Mn | 326.92 Mn | 19.12 Mn | -10.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.80% |
| Dec 31, 2025 | -12.56% |
| Sep 30, 2025 | 25.79% |
| Jun 30, 2025 | 335,520.44% |
| Mar 31, 2025 | 92.99% |
| Dec 31, 2024 | 247.41% |
| Sep 30, 2024 | -99.78% |
| Jun 30, 2024 | 114.37% |
| Mar 31, 2024 | -98.60% |
| Dec 31, 2023 | -30.91% |
| Sep 30, 2023 | 70.49% |
| Jun 30, 2023 | 214.69% |
| Mar 31, 2023 | 117,379.67% |
| Dec 31, 2022 | 221.68% |
| Sep 30, 2022 | 318,756.72% |
| Jun 30, 2022 | -319.31% |
| Mar 31, 2022 | -92.96% |
| Dec 31, 2021 | -184.99% |
| Sep 30, 2021 | -108.99% |
| Jun 30, 2021 | -79.83% |